Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
DAIREI, Last Fiscal Year Net Income Revised Downward to a Loss
2883 DAIREI CO.,LTD 【J-GAAP】
Guidance Update ReportDAIREI CO.,LTD <2883> [TSE Std] announced a performance revision after the market closed on April 25th (16:00). The net income/loss (non-consolidated) for the fiscal year ending March 2025 has been revised downward from an expected profit of 627 million yen to a loss of 543 million yen (compared to a profit of 766 million yen in the previous period), turning to a loss outlook.
Based on the downwardly revised full-year plan announced by the company, our calculation indicates that the October to March period (2H) net income/loss has been revised downward from an expected profit of 375 million yen to a loss of 795 million yen (compared to a profit of 368 million yen in the same period of the previous year), turning to a loss outlook.
Kabutan News
Guidance Update
Second Half Update
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2024 Prev | 12,901 | 510 | 533 | 375 | 63.5 | 60 | Jan 31, 2025 | J-GAAP |
Oct - Mar, 2024 New | 12,773 | 460 | 487 | -795 | -134.5 | 60 | Apr 25, 2025 | J-GAAP |
Revision Rate | -1.0% | -9.8% | -8.6% | - | - |
Full Year Update
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2025 Prev | 25,900 | 930 | 930 | 627 | 106.1 | 60 | Jan 31, 2025 | J-GAAP |
Mar, 2025 New | 25,772 | 880 | 884 | -543 | -91.9 | 60 | Apr 25, 2025 | J-GAAP |
Revision Rate | -0.5% | -5.4% | -4.9% | - | - |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 13,452 | 506 | 514 | 368 | 62.3 | 60 | May 10, 2024 | J-GAAP |
Oct - Mar, 2024 Guidance | 12,773 | 460 | 487 | -795 | -134.5 | 60 | Apr 25, 2025 | J-GAAP |
YoY | -5.0% | -9.1% | -5.3% | - | - |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 27,239 | 1,525 | 1,537 | 1,023 | 173.3 | 60 | May 10, 2023 | J-GAAP |
Mar, 2024 | 27,416 | 1,066 | 1,104 | 766 | 129.8 | 60 | May 10, 2024 | J-GAAP |
Mar, 2025 Guidance | 25,772 | 880 | 884 | -543 | -91.9 | 60 | Apr 25, 2025 | J-GAAP |
YoY | -6.0% | -17.4% | -19.9% | - | - |
Related Articles
Daito Chemix, Last Fiscal Year Net Income Revised Upward by 2.4 times, Dividend Revised Upward by 6 yen
ASAHI KOGYOSHA, Last Fiscal Year Ordinary Profit Revised Upward by 12%, Raises Record High Profit Forecast, Dividend Revised Upward by 10 yen
ALMETAX MANUFACTURING, Last Fiscal Year Ordinary Profit Revised Downward to a Loss
NITTO DENKO, 9% Decrease in Net Income for The Current Fiscal Year, Dividend Effectively Increased
WAKAMOTO PHARMA, Last Fiscal Year's Undisclosed Ordinary Loss to Widen
NIPPON RIETEC, Last Fiscal Year Ordinary Profit Revised Upward by 29%
Mitsubishi Research Institute, The Current Fiscal Year Ordinary Profit Revised Downward to an Unexpected 8% Decrease
Nextgen, Last Fiscal Year Ordinary Profit Revised Upward by 32%, Highest in Nine Terms
KEYENCE, 8% Increase in Ordinary Profit for the Last Fiscal Year, Current period performance is undisclosed.
TAKAOKA TOKO, 0.03% Decrease in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 24 yen